Outcome | Pretreatment | Posttreatment | ANCOVA | ||||
---|---|---|---|---|---|---|---|
 | RT + mCIT | RT | RT + mCIT | RT |  |  |  |
 | (n = 17) | (n = 17) | (n = 17) | (n = 17) | F | P | Partial η 2 |
WMFT-FAS | 2.21 ± 0.4 | 2.74 ± 0.68 | 2.59 ± 0.46 | 2.89 ± 0.68 | 6.78 | .01* | 0.18 |
WMFT-TIME | 6.28 ± 2.22 | 6.81 ± 5.22 | 4.84 ± 1.45 | 7.19 ± 6.66 | 2.67 | .11 | 0.08 |
NEADL | 20.15 ± 11.24 | 32.9 ± 14.22 | 26.44 ± 11.82 | 33.89 ± 15.31 | 6.35 | .02* | 0.17 |
FIM | 119.47 ± 3.99 | 116.18 ± 7.08 | 122 ± 2.78 | 117.53 ± 7.13 | 3.61 | .07 | 0.10 |